ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $190.39bn
- $217.85bn
- $44.33bn
Abbott jumps, set for best day since 2002 after lifting profit forecast
Abbott Laboratories reports results for the quarter ended June 30 - Earnings Summary
Abbott Laboratories reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott, Citizens Financial, Lululemon Athletica
Abbott raises 2026 profit forecast on strength in diagnostics, medical devices (updated)
Abbott rises after raising annual profit forecast on heart device demand
Abbott beats Q2 profit estimates, raises full-year forecast
Brief: Abbott Q2 Adjusted EPS USD 1.31 Vs. IBES Estimate USD 1.28
Abbott raises 2026 profit forecast on heart device strength
Analysts see risks for elective-procedure medtechs after HCA cuts profit forecast
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula (updated)
Brief: FDA Approves Abbott HIV Combo Next Assay
Press Digest: Wall Street Journal - June 29
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports (updated)
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
Factbox: Major deals involving US drugmakers and biotechs over the past decade
ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test
Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher court